The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Rituximab
Australian Public Assessment Report
Device/Product Name
Ruxience
Active ingredients
Rituximab
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-00593-1-6
Submission Type
New biosimilar
Decision
Approved